Total Payments
$14,372
2024 Payments
$1,712
Companies
57
Transactions
744
Medicare Patients
2,275
Medicare Billing
$562,179
Payment Breakdown by Category
Food & Beverage$14,337 (99.8%)
Travel$24.96 (0.2%)
Education$10.24 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,337 | 739 | 99.8% |
| Travel and Lodging | $24.96 | 1 | 0.2% |
| Education | $10.24 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,471 | 65 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,439 | 100 | $0 (2024) |
| Nevro Corp. | $1,149 | 24 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $858.16 | 68 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $752.30 | 36 | $0 (2024) |
| Abbott Laboratories | $741.98 | 15 | $0 (2024) |
| PFIZER INC. | $729.66 | 57 | $0 (2024) |
| ABBVIE INC. | $694.05 | 43 | $0 (2024) |
| Amgen Inc. | $666.07 | 25 | $0 (2022) |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | $482.69 | 27 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,712 | 87 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($395.71) |
| 2023 | $1,559 | 75 | Scilex Pharmaceuticals Inc. ($216.53) |
| 2022 | $2,086 | 93 | Boston Scientific Corporation ($343.18) |
| 2021 | $1,549 | 75 | Amgen Inc. ($272.35) |
| 2020 | $1,295 | 68 | Nevro Corp. ($267.47) |
| 2019 | $1,731 | 81 | Nevro Corp. ($499.25) |
| 2018 | $2,023 | 114 | Abbott Laboratories ($329.92) |
| 2017 | $2,419 | 151 | BOSTON SCIENTIFIC CORPORATION ($511.00) |
All Payment Transactions
744 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: PAIN | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Analgesic | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: PAIN | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: PAIN | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Gastroenterology | ||||||
| 10/18/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Analgesic | ||||||
| 09/29/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| 09/24/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $13.90 | General |
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 621 | 1,664 | $1.3M | $165,206 |
| 2022 | 12 | 656 | 1,640 | $882,450 | $144,598 |
| 2021 | 9 | 470 | 1,503 | $537,315 | $127,978 |
| 2020 | 15 | 528 | 1,550 | $893,665 | $124,397 |
Total Patients
2,275
Total Services
6,357
Medicare Billing
$562,179
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 733 | $238,225 | $71,411 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 566 | $141,500 | $35,672 | 25.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 19 | 22 | $93,000 | $9,754 | 10.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 29 | 48 | $163,500 | $8,829 | 5.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 16 | 28 | $163,800 | $6,690 | 4.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 18 | 29 | $111,000 | $6,683 | 6.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 20 | 32 | $128,000 | $6,614 | 5.2% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 11 | 23 | $71,940 | $4,427 | 6.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 27 | 45 | $150,420 | $4,317 | 2.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $18,900 | $3,641 | 19.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 57 | $19,380 | $2,874 | 14.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $6,300 | $1,874 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $7,200 | $1,862 | 25.9% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 12 | 16 | $7,200 | $556.58 | 7.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 237 | 863 | $215,750 | $59,289 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 514 | $167,050 | $52,151 | 31.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 12 | 14 | $48,000 | $5,846 | 12.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 22 | 31 | $93,740 | $5,617 | 6.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 13 | 19 | $130,200 | $5,377 | 4.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 12 | 16 | $54,000 | $3,499 | 6.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 31 | 43 | $6,450 | $3,153 | 48.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $10,200 | $3,142 | 30.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 19 | 28 | $74,760 | $2,544 | 3.4% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 12 | 14 | $63,000 | $2,197 | 3.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 19 | 26 | $11,700 | $1,157 | 9.9% |
About Dr. Sunil Chandy, M.D
Dr. Sunil Chandy, M.D is a Pain Medicine healthcare provider based in Exton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1720375793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Chandy, M.D has received a total of $14,372 in payments from pharmaceutical and medical device companies, with $1,712 received in 2024. These payments were reported across 744 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($14,337).
As a Medicare-enrolled provider, Chandy has provided services to 2,275 Medicare beneficiaries, totaling 6,357 services with total Medicare billing of $562,179. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Exton, PA
- Active Since 06/29/2011
- Last Updated 08/06/2013
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1720375793
Products in Payments
- RELISTOR (Drug) $1,259
- Senza Spinal Cord Stimulation System (Device) $807.20
- Aimovig (Biological) $643.86
- ZTLido (Drug) $600.27
- NURTEC ODT (Drug) $545.83
- Horizant (Drug) $517.55
- UBRELVY (Drug) $498.33
- CLINICAL TRIAL PRODUCT (Device) $383.10
- XTAMPZA (Drug) $365.31
- General - Pain Management (Device) $346.21
- LYRICA (Drug) $317.71
- Trudhesa (Drug) $281.59
- PROCLAIM (Device) $280.06
- SPECTRA WAVEWRITER (Device) $269.68
- QULIPTA (Drug) $253.63
- RELISTOR ORAL (Drug) $253.60
- Omnia (Device) $238.28
- BUNAVAIL 2.1 mg 30-count box (Drug) $236.72
- BELBUCA (Drug) $233.96
- Belbuca (Drug) $227.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.